Aastrom Biosciences Inc (NASDAQ:ASTM)

Data as of Sep 22
 -0.12 / -4.38%
Today’s Change
Today|||52-Week Range
Health Technology
Medical Specialties

Company Description

Aastrom Biosciences, Inc. is a regenerative medicine company which engages in the development of patient-specific, expanded multicellular therapies for use in the treatment of severe, chronic ischemic cardiovascular diseases. The company's research and product development involves in the development of patient specific cell products for use in regenerative medicine. Its proprietary cell-manufacturing technology enables the manufacture of Ixmyelocel-T, a patient-specific, multicellular therapy, expanded from an adult's own bone marrow, and delivered directly to damaged tissues. Aastrom Biosciences was founded on March 24, 1989 and is headquartered in Ann Arbor, MI.

Contact Information

Aastrom Biosciences, Inc.
Domino's Farms, Lobby K
Ann Arbor Michigan 48105-9484
P:(734) 418-4400
Investor Relations:



Individual stakeholders3.85%
Other institutional17.90%
Mutual fund holders0.90%

Top Executives

Dominick C. ColangeloPresident, CEO, Treasurer, Director & CAO
Daniel R. OrlandoChief Operating Officer
Gerard J. MichelChief Financial Officer & VP-Corporate Development
Ross TuboChief Scientific Officer
David ReckerChief Medical Officer

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.